FI106380B - Menetelmä verihiutaleaggregaatiota ja veritukoksen muodostusta inhiboivan N-[8-[(aminoiminometyyli)amino]-1-okso-oktyyli]-N-L-alfa-aspartyyli-L-fenyylialaniinin valmistamiseksi - Google Patents

Menetelmä verihiutaleaggregaatiota ja veritukoksen muodostusta inhiboivan N-[8-[(aminoiminometyyli)amino]-1-okso-oktyyli]-N-L-alfa-aspartyyli-L-fenyylialaniinin valmistamiseksi Download PDF

Info

Publication number
FI106380B
FI106380B FI913006A FI913006A FI106380B FI 106380 B FI106380 B FI 106380B FI 913006 A FI913006 A FI 913006A FI 913006 A FI913006 A FI 913006A FI 106380 B FI106380 B FI 106380B
Authority
FI
Finland
Prior art keywords
asp
platelet
phe
blood
platelet aggregation
Prior art date
Application number
FI913006A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI913006A0 (fi
FI913006A (fi
Inventor
Foe Siong Tjoeng
Steven Paul Adams
Larry Philip Feigen
Original Assignee
Searle & Co
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co, Monsanto Co filed Critical Searle & Co
Publication of FI913006A0 publication Critical patent/FI913006A0/fi
Publication of FI913006A publication Critical patent/FI913006A/fi
Application granted granted Critical
Publication of FI106380B publication Critical patent/FI106380B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
FI913006A 1990-06-20 1991-06-19 Menetelmä verihiutaleaggregaatiota ja veritukoksen muodostusta inhiboivan N-[8-[(aminoiminometyyli)amino]-1-okso-oktyyli]-N-L-alfa-aspartyyli-L-fenyylialaniinin valmistamiseksi FI106380B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54095390 1990-06-20
US07/540,953 US5053393A (en) 1988-07-20 1990-06-20 Novel platelet-aggregation inhibitor

Publications (3)

Publication Number Publication Date
FI913006A0 FI913006A0 (fi) 1991-06-19
FI913006A FI913006A (fi) 1991-12-21
FI106380B true FI106380B (fi) 2001-01-31

Family

ID=24157584

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913006A FI106380B (fi) 1990-06-20 1991-06-19 Menetelmä verihiutaleaggregaatiota ja veritukoksen muodostusta inhiboivan N-[8-[(aminoiminometyyli)amino]-1-okso-oktyyli]-N-L-alfa-aspartyyli-L-fenyylialaniinin valmistamiseksi

Country Status (17)

Country Link
US (1) US5053393A (ja)
EP (1) EP0462960B1 (ja)
JP (1) JPH0651719B2 (ja)
KR (1) KR940000753B1 (ja)
AT (1) ATE123293T1 (ja)
AU (1) AU631070B2 (ja)
CA (1) CA2044978C (ja)
DE (1) DE69110091T2 (ja)
DK (1) DK0462960T3 (ja)
ES (1) ES2075415T3 (ja)
FI (1) FI106380B (ja)
IE (1) IE72519B1 (ja)
IL (1) IL98557A (ja)
NO (1) NO301373B1 (ja)
NZ (1) NZ238611A (ja)
PT (1) PT98026B (ja)
ZA (1) ZA914728B (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332726A (en) * 1989-09-29 1994-07-26 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic peptides and pseudopeptides
TW201303B (ja) * 1990-07-05 1993-03-01 Hoffmann La Roche
US5260277A (en) * 1990-09-10 1993-11-09 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
MX9201416A (es) * 1991-03-28 1992-10-01 Rhone Poulenc Rorer Int Peptidos y pseudopeptidos antitromboticos.
DE4126277A1 (de) * 1991-08-08 1993-02-11 Cassella Ag Hydantoinderivate
US5239113A (en) * 1991-10-15 1993-08-24 Monsanto Company Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof
US5625093A (en) * 1991-10-15 1997-04-29 G. D. Searle & Co. Substituted β-amino acid derivatives useful as platelet aggregation inhibitors
US5254573A (en) * 1991-10-15 1993-10-19 Monsanto Company Substituted heterocyclic derivatives useful as platelet aggregation inhibitors
WO1993008823A1 (en) * 1991-11-06 1993-05-13 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
US5258398A (en) * 1991-12-16 1993-11-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic diaminoalkanoic acid derivatives
TW223629B (ja) * 1992-03-06 1994-05-11 Hoffmann La Roche
US5338725A (en) * 1992-06-30 1994-08-16 The Research Foundation Of The State University Of New York Anti-aggregatory agents for platelets
US6380163B1 (en) * 1992-12-22 2002-04-30 Baxter International Inc. Peritoneal dialysis solutions with polypeptides
DE4302485A1 (de) * 1993-01-29 1994-08-04 Merck Patent Gmbh Piperazinderivate
AU687790B2 (en) * 1993-02-09 1998-03-05 Biogen Idec Ma Inc. Treatment for insulin dependent diabetes
EP0623615B1 (de) * 1993-05-01 1999-06-30 MERCK PATENT GmbH Substituierte 1-Phenyl-oxazolidin-2-on Derivate, deren Herstellung und deren Verwendung als Adhäsionsrezeptor-Antagonisten
TW394760B (en) * 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
DE4405378A1 (de) * 1994-02-19 1995-08-24 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE4429461A1 (de) * 1994-08-19 1996-02-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
ES2123889T3 (es) 1994-11-02 1999-01-16 Merck Patent Gmbh Antagonistas de receptores de adhesion.
DE4439846A1 (de) * 1994-11-08 1996-05-09 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE19504954A1 (de) * 1995-02-15 1996-08-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE19516483A1 (de) * 1995-05-05 1996-11-07 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
US5891418A (en) * 1995-06-07 1999-04-06 Rhomed Incorporated Peptide-metal ion pharmaceutical constructs and applications
US7018627B1 (en) 1995-06-07 2006-03-28 Icos Corporation Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances, and uses thereof
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
US5872122A (en) * 1997-10-16 1999-02-16 Monsanto Company Pyrimidinylamidino β-amino acid derivatives useful as inhibitors of platelet aggregation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948B1 (ja) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma
US4127580A (en) * 1975-02-07 1978-11-28 Parcor Process for the preparation of thieno-pyridine derivatives
US4661111A (en) * 1982-08-04 1987-04-28 La Jolla Cancer Research Foundation Polypeptide
US4589881A (en) * 1982-08-04 1986-05-20 La Jolla Cancer Research Foundation Polypeptide
US4517686A (en) * 1982-08-04 1985-05-21 La Jolla Cancer Research Foundation Polypeptide
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
US4614517A (en) * 1982-08-04 1986-09-30 La Jolla Cancer Research Foundation Tetrapeptide
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US4992463A (en) * 1988-07-20 1991-02-12 Monsanto Company Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US5169836A (en) * 1988-11-10 1992-12-08 Trustees Of The University Of Penna. Inhibitors of platelet binding
CA2008116C (en) * 1989-02-23 2001-11-20 Thomas Weller Glycine derivatives

Also Published As

Publication number Publication date
NZ238611A (en) 1992-09-25
DK0462960T3 (da) 1995-10-02
US5053393A (en) 1991-10-01
FI913006A0 (fi) 1991-06-19
DE69110091D1 (de) 1995-07-06
KR920000785A (ko) 1992-01-29
NO912396L (no) 1991-12-23
IL98557A (en) 1996-01-31
DE69110091T2 (de) 1996-02-08
IL98557A0 (en) 1992-07-15
AU7912191A (en) 1992-01-02
AU631070B2 (en) 1992-11-12
IE72519B1 (en) 1997-04-23
NO301373B1 (no) 1997-10-20
ATE123293T1 (de) 1995-06-15
IE912100A1 (en) 1992-01-01
NO912396D0 (no) 1991-06-19
KR940000753B1 (ko) 1994-01-29
EP0462960A1 (en) 1991-12-27
PT98026B (pt) 1998-11-30
PT98026A (pt) 1992-04-30
CA2044978C (en) 2001-06-12
JPH04230299A (ja) 1992-08-19
FI913006A (fi) 1991-12-21
JPH0651719B2 (ja) 1994-07-06
ES2075415T3 (es) 1995-10-01
ZA914728B (en) 1993-02-24
EP0462960B1 (en) 1995-05-31
CA2044978A1 (en) 1991-12-21

Similar Documents

Publication Publication Date Title
FI106380B (fi) Menetelmä verihiutaleaggregaatiota ja veritukoksen muodostusta inhiboivan N-[8-[(aminoiminometyyli)amino]-1-okso-oktyyli]-N-L-alfa-aspartyyli-L-fenyylialaniinin valmistamiseksi
EP0319506B1 (en) Novel platelet-aggregation inhibitor peptide derivatives
EP0352249B1 (en) Novel platelet-aggregation inhibitors
US5493007A (en) Platelet aggregation inhibitors having high specificity for GPIIBIIIA
JP3042887B2 (ja) 血栓塞栓症疾患を診断するための像形成剤としての放射線標識された血小板ＧＰ▲ＩＩ▼ｂ／▲ＩＩＩ▼ａ受容体アンタゴニスト
SK282391B6 (sk) Cyklopeptid, spôsob jeho prípravy, použitie a farmaceutický prostriedok, ktorý ho obsahuje
PT2077995E (pt) Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa
US5498601A (en) Platelet aggregation-inhibiting peptides
Cook et al. Inhibition of platelet hemostatic plug formation by trigramin, a novel RGD-peptide
JPH07278091A (ja) 抗血栓症剤
Tandon et al. Interaction of human platelets with laminin and identification of the 67 kDa laminin receptor on platelets
RU2287580C2 (ru) Рекомбинантный рецептор коллагена на тромбоцитах гликопротеин vi и его применение в фармацевтике
JP3489628B2 (ja) 血小板凝集阻害剤
Calzada et al. Novel integrin antagonists derived from thrombospondins
JPH09509936A (ja) 抗血栓剤
JPH107671A (ja) 抗血栓性ジアミド
JPH06504989A (ja) 新規の抗凝固作用を有するペプチド
AU734935B2 (en) Bradykinin analogs as selective inhibitors of cell activation
RU2396271C1 (ru) Rgd-подобные пептиды
JPH089635B2 (ja) 新規ペプチド化合物
JPH0797397A (ja) 新規ペプチド及びそれを用いた血小板凝集抑制剤
JPH07309894A (ja) 新規ペプチド並びにそれを用いた血小板凝集抑制剤、体外循環用血液凝固抑制剤及び輸血用血小板製剤保護剤
WO1992022580A1 (fr) Nouvel agent inhibiteur de l'adhesion de neutrophiles d'origine humaine et composition pharmaceutique contenant cet agent

Legal Events

Date Code Title Description
MA Patent expired